DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 3 USDMF

3 API Suppliers
3 USDMF

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl, 2 Actylis, 1 BioSpectra

relatedExcipients
1 Pfanstiehl
2 Actylis
1 BioSpectra

EXCIPIENTS BY APPLICATIONS

4 Parenteral, 1 Topical

excipientsByApplications
4 Parenteral
1 Topical

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

4 RELATED EXCIPIENT COMPANIES

5EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Popg na, l-, Popg na, r-, Popg-na, l-, Popg-na, r-, 268550-95-4, 202070-86-8

Molecular Formula

C₄₀H₇₆NaO₁₀P

Molecular Weight

771.0 g/mol

InChI Key

FJXDNGDRHUDFST-XQYKCTAGSA-M

FDA UNII

T52TI8BMQ6

1 2D Structure

POPG

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

sodium;2,3-dihydroxypropyl [(2R)-3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] phosphate

2.1.2 InChI

InChI=1S/C40H77O10P.Na/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2;/h17-18,37-38,41-42H,3-16,19-36H2,1-2H3,(H,45,46);/q;+1/p-1/b18-17-;/t37?,38-;/m1./s1

2.1.3 InChI Key

FJXDNGDRHUDFST-XQYKCTAGSA-M

2.1.4 Canonical SMILES

CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC(CO)O)OC(=O)CCCCCCCC=CCCCCCCCC.[Na+]

2.1.5 Isomeric SMILES

CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC(CO)O)OC(=O)CCCCCCC/C=C\CCCCCCCC.[Na+]

2.2 Other Identifiers

2.2.1 UNII

T52TI8BMQ6

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Popg Na, L-

2. Popg Na, R-

3. Popg-na, L-

4. Popg-na, R-

5. 268550-95-4

6. 202070-86-8

7. T52ti8bmq6

8. 1-palmitoyl-2-oleoyl-phosphatidyl-glycerol Sodium

9. Sodium;2,3-dihydroxypropyl [(2r)-3-hexadecanoyloxy-2-[(z)-octadec-9-enoyl]oxypropyl] Phosphate

10. 383907-64-0

11. 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)), Sodium Salt

12. 9-octadecenoic Acid (9z)-, (1r)-1-((((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)methyl)-2-((1-oxohexadecyl)oxy)ethyl Ester, Sodium Salt (1:1)

13. Sodium 2,3-dihydroxypropyl ((2r)-3-hexadecanoyloxy-2-((z)-octadec-9-enoyl)oxy-propyl) Phosphate

14. Sodium 1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol))

15. 1-palmitoyl-2-oleyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt

16. Sodium 2,3-dihydroxypropyl ((r)-2-(oleoyloxy)-3-(palmitoyloxy)propyl) Phosphate(z)

17. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium Salt)

18. Unii-t52ti8bmq6

19. Epg-na

20. Popg-na

21. Starbld0000181

22. 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-sn-1-glycerol Sodium Salt

23. L-a-phosphatidylglycerols (egg)

24. Surfaxin Component Popg, Na

25. Mfcd00674290

26. Lucinactant Component Popg, Na

27. Bp-26321

28. Bp-26334

29. Hy-130463

30. Cs-0108062

31. T72199

32. J-016573

33. Non-hydrogenated Egg Phosphatidylglycerol, Sodium Salt

34. Q27289682

35. Egg Pg, L-alpha-phosphatidylglycerol (egg, Chicken) (sodium Salt), Powder

36. 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) Sodium Salt, >=98.0% (tlc)

37. Egg Pg, L-alpha-phosphatidylglycerol (egg, Chicken) (sodium Salt), Chloroform

38. (2r)-1-(((2,3-dihydroxypropoxy)(hydroxy)phosphoryl)oxy)-3-(palmitoyloxy)propan-2-yl Oleate, Sodium Salt(1:x)

39. 16:0-18:1 Pg, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium Salt), Powder

40. Phosphoric Acid Sodium 2,3-dihydroxypropyl[(2r)-2-(oleoyloxy)-3-(palmitoyloxy)propyl] Ester Salt

2.4 Create Date

2010-09-24

3 Chemical and Physical Properties

Molecular Formula	C₄₀H₇₆NaO₁₀P
Molecular Weight	771.0 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	41
Exact Mass	770.50737990 g/mol
Monoisotopic Mass	770.50737990 g/mol
Topological Polar Surface Area	152 Å²
Heavy Atom Count	52
Formal Charge	0
Complexity	875
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

Topical

ABOUT THIS PAGE

Find POPG manufacturers, exporters & distributors on PharmaCompass

POPG

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

3 USDMF

RELATED EXCIPIENT COMPANIES

1 Pfanstiehl

2 Actylis

1 BioSpectra

EXCIPIENTS BY APPLICATIONS

4 Parenteral

1 Topical

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

4 RELATED EXCIPIENT COMPANIES

5EXCIPIENTS BY APPLICATIONS

What are you looking for?